Implications of human induced pluripotent stem cells in metabolic disorders: from drug discovery toward precision medicine-Reference-Cited by-同舟云学术

Implications of human induced pluripotent stem cells in metabolic disorders: from drug discovery toward precision medicine

Published:2019-01 Issue:1 Volume:24 Page:334-341
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Cota-Coronado Agustin,Ramírez-Rodríguez P. Berenice,Padilla-Camberos Eduardo,Díaz éNstor F.,Flores-Fernández Jose M.,Ávila-Gónzalez Daniela,Diaz-Martinez N. Emmanuel

Funder

CONACyT

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference96 articles.

1. Inflammasomes and metabolic disorders: old genes in modern diseases;Robbins;Mol. Cell.,2014

2. Modulation of gut microbiota in the management of metabolic disorders: the prospects and challenges;Erejuwa;Int. J. Mol. Sci.,2014

3. Amlodipine enhances amelioration of vascular insulin resistance, oxidative stress, and metabolic disorders by candesartan in metabolic syndrome rats;Sueta;Am. J. Hypertens.,2012

4. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran;Tehrani;Reprod. Biol. Endocrinol.,2014

5. High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome;Lai;Biol. Reprod.,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induced Pluripotent Stem Cells and CRISPR-Cas9 Innovations for Treating Alpha-1 Antitrypsin Deficiency and Glycogen Storage Diseases;Cells;2024-06-18

2. Vascular cells differentiated from peripheral blood mononuclear cell- versus urine cell-derived induced pluripotent stem cells: A comparative analysis;2023-06-30

3. Recent advances in the use of CRISPR/Cas for understanding the early development of molecular gaps in glial cells;Frontiers in Cell and Developmental Biology;2022-09-02

4. Droplet Microarray Based Screening Identifies Proteins for Maintaining Pluripotency of hiPSCs;Advanced Healthcare Materials;2022-07-20

5. Improving the safety of iPSC-derived T cell therapy;Molecular Players in iPSC Technology;2022